BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

685 related articles for article (PubMed ID: 29495520)

  • 1. Current Insights into Oral Cancer Epigenetics.
    Irimie AI; Ciocan C; Gulei D; Mehterov N; Atanasov AG; Dudea D; Berindan-Neagoe I
    Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic alterations in cancer.
    Ilango S; Paital B; Jayachandran P; Padma PR; Nirmaladevi R
    Front Biosci (Landmark Ed); 2020 Mar; 25(6):1058-1109. PubMed ID: 32114424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic modifications in multiple myeloma: recent advances on the role of DNA and histone methylation.
    Amodio N; D'Aquila P; Passarino G; Tassone P; Bellizzi D
    Expert Opin Ther Targets; 2017 Jan; 21(1):91-101. PubMed ID: 27892767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combinatorial epigenetic regulation of non-coding RNAs has profound effects on oncogenic pathways in breast cancer subtypes.
    Xu J; Wang Z; Li S; Chen J; Zhang J; Jiang C; Zhao Z; Li J; Li Y; Li X
    Brief Bioinform; 2018 Jan; 19(1):52-64. PubMed ID: 27742663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Tox21 Approach to Altered Epigenetic Landscapes: Assessing Epigenetic Toxicity Pathways Leading to Altered Gene Expression and Oncogenic Transformation In Vitro.
    Parfett CL; Desaulniers D
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28587163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of noncoding RNAs in epigenetic modifications of esophageal cancer.
    Xiao Y; Su M; Ou W; Wang H; Tian B; Ma J; Tang J; Wu J; Wu Z; Wang W; Zhou Y
    Biomed Pharmacother; 2019 Sep; 117():109192. PubMed ID: 31387188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic mechanisms in oral carcinogenesis.
    Gasche JA; Goel A
    Future Oncol; 2012 Nov; 8(11):1407-25. PubMed ID: 23148615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetics in lung cancer diagnosis and therapy.
    Mehta A; Dobersch S; Romero-Olmedo AJ; Barreto G
    Cancer Metastasis Rev; 2015 Jun; 34(2):229-41. PubMed ID: 25939322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging role of non-coding RNA in oral cancer.
    Momen-Heravi F; Bala S
    Cell Signal; 2018 Jan; 42():134-143. PubMed ID: 29056500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic biomarkers in prostate cancer: Current and future uses.
    Chiam K; Ricciardelli C; Bianco-Miotto T
    Cancer Lett; 2014 Jan; 342(2):248-56. PubMed ID: 22391123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic disregulation in oral cancer.
    Mascolo M; Siano M; Ilardi G; Russo D; Merolla F; Rosa G; Staibano S
    Int J Mol Sci; 2012; 13(2):2331-2353. PubMed ID: 22408457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of epigenetic modifications in luminal breast cancer.
    Abdel-Hafiz HA; Horwitz KB
    Epigenomics; 2015 Aug; 7(5):847-62. PubMed ID: 25689414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic Modifications and Head and Neck Cancer: Implications for Tumor Progression and Resistance to Therapy.
    Castilho RM; Squarize CH; Almeida LO
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28704968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deciphering the Epigenetic Symphony of Cancer: Insights and Epigenetic Therapies Implications.
    Akram F; Tanveer R; Andleeb S; Shah FI; Ahmad T; Shehzadi S; Akhtar AM; Syed G
    Technol Cancer Res Treat; 2024; 23():15330338241250317. PubMed ID: 38780251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-translational histone modifications in circulating nucleosomes as new biomarkers in colorectal cancer.
    Gezer U; Holdenrieder S
    In Vivo; 2014; 28(3):287-92. PubMed ID: 24815828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Promises to Cure Cancer and Other Genetic Diseases/Disorders: Epi-drugs Through Epigenetics.
    Duan YT; Sangani CB; Liu W; Soni KV; Yao Y
    Curr Top Med Chem; 2019; 19(12):972-994. PubMed ID: 31161992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetics in prostate cancer: biologic and clinical relevance.
    Jerónimo C; Bastian PJ; Bjartell A; Carbone GM; Catto JW; Clark SJ; Henrique R; Nelson WG; Shariat SF
    Eur Urol; 2011 Oct; 60(4):753-66. PubMed ID: 21719191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetics and vascular diseases.
    Stratton MS; Farina FM; Elia L
    J Mol Cell Cardiol; 2019 Aug; 133():148-163. PubMed ID: 31211956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer type-specific epigenetic changes: gastric cancer.
    Calcagno DQ; de Arruda Cardoso Smith M; Burbano RR
    Methods Mol Biol; 2015; 1238():79-101. PubMed ID: 25421656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.